Azor and Bydureon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Bydureon (exenatide synthetic). Common drug interactions include renal failure among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Azor and Bydureon. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Bydureon?

Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.

On Jul, 08, 2026

11 people who take Azor and Bydureon together, and have interactions are studied.

What are the common drug interactions of Azor and Bydureon, by gender? *:

female:

Renal failure (kidney dysfunction)
Blood glucagon increased
Fatigue (feeling of tiredness)
Weight fluctuation
Weight increased
Asthenia (weakness)
Blood glucose increased
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Injection site erythema (redness at injection site)
Injection site pain

male:

Pain in extremity
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Dysuria (painful or difficult urination)
Increased appetite
Injection site bruising
Injection site haemorrhage (bleeding from injection site)
Pruritus genital (uneasy irritation of the skin of the vagina and the surrounding area)

What are the common drug interactions of Azor and Bydureon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)

50-59:

n/a

60+:

Injection site haemorrhage (bleeding from injection site)
Blood glucagon increased
Dysuria (painful or difficult urination)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Increased appetite
Injection site erythema (redness at injection site)
Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
Injection site pain
Injection site swelling
Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

High Blood Cholesterol: 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Blood Pressure Abnormal: 2 people, 18.18%
Prostate Infection: 1 person, 9.09%
Pain: 1 person, 9.09%
Neuralgia (pain in one or more nerves): 1 person, 9.09%
Joint Pain: 1 person, 9.09%
Infection: 1 person, 9.09%
Indigestion: 1 person, 9.09%
Hypersensitivity: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Bydureon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously